You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR ARIMOCLOMOL CITRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ARIMOCLOMOL CITRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03491462 ↗ Arimoclomol in Amyotropic Lateral Sclerosis Completed Orphazyme Phase 3 2018-07-31 A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic lateral sclerosis (ALS)
NCT03836716 ↗ Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial Terminated Orphazyme Phase 3 2019-09-19 A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with Amyotrophic Lateral Sclerosis (ALS)who have completed the ORARIALS-01 trial.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ARIMOCLOMOL CITRATE

Condition Name

Condition Name for ARIMOCLOMOL CITRATE
Intervention Trials
Amyotrophic Lateral Sclerosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ARIMOCLOMOL CITRATE
Intervention Trials
Sclerosis 2
Motor Neuron Disease 2
Amyotrophic Lateral Sclerosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ARIMOCLOMOL CITRATE

Trials by Country

Trials by Country for ARIMOCLOMOL CITRATE
Location Trials
United States 16
Canada 3
Germany 2
Poland 2
France 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ARIMOCLOMOL CITRATE
Location Trials
Virginia 2
Pennsylvania 2
Oregon 2
New York 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ARIMOCLOMOL CITRATE

Clinical Trial Phase

Clinical Trial Phase for ARIMOCLOMOL CITRATE
Clinical Trial Phase Trials
Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ARIMOCLOMOL CITRATE
Clinical Trial Phase Trials
Terminated 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ARIMOCLOMOL CITRATE

Sponsor Name

Sponsor Name for ARIMOCLOMOL CITRATE
Sponsor Trials
Orphazyme 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ARIMOCLOMOL CITRATE
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.